Abstract:Objective:To investigate the efficacy and safety of the cold-cycle microwave ablation in combination with TACE in treating primary hepatocarcinoma.Methods:Forty-five cases of primary hepatocarcinoma were chosen.They were treated with trans-hepatic arterial in fusion chemotherapy and embolism(TACE).Most chemotherapeutic regimens were two-agent combinations(EPI+CDDP,GEM+CDDP or 5-FU+CDDP),and embolism agents included superliquid lipiodol(dose was given based on the volume and blood supply of tumor and hepatic function,usually 5 to 15 ml) and gelatin sponge.Patients whose tumors were well lipiodol-deposited were treated with TACE once a month for two to three times,then their reciduary foci were further treated with cold-cycle microwave ablation(power was 50 to 60W,each locus should be treated for 20 to 30 minutes).For patients whose tumors were badly lipiodol-deposited because of poor blood supply,they received cold-cycle microwave ablation after the first TACE(with the same power and time as those aforementioned).When all treatments finished,alterations of embolism/melt degree of loci,clinical symptoms,AFP and liver/kidney functions and blood regular test were evaluated by weighted CT,MR or DSA(digital subtract angiography) tests.Follow-up time was 3 years after the last treatment.Results:Among 45 patients with primary hepatocarcinoma,34 cases had hypervascular tumors and underwent TACE treatment,including 0 of CR,70.6%(24 of 34) of PR,17.6%(6 of 34) of SD and 11.8%(4 of 34) of PD,which achieved a clinical beneficial rate of 88.2%.Up to 62 hypervascular and hypovascular loci remained after TACE treatment.Under cold-cycle microwave ablation therapy,complete necrosis of loci occurred in 48 cases(77.4%),incomplete necrosis of loci occurred in 5 cases(8.1%) and partial necrosis of loci occurred in 9 cases(14.5%).11 cases had AFP beyond 400μg/L prior to cold-cycle microwave ablation therapy,AFP of 7 cases dropped to normal level,AFP of 2 cases decreased significantly compared with that of pretreatment,2 cases showed no change in AFP.The 1-,2-and 3-year survival rates were 73.3%,62.2% and 37.8%,respectively.The main chemotherapy-associated side effects included nausea,vomiting and anorexia,aleucocytosis and thrombocytopenia were within grade Ⅱ to Ⅲ.Embolism and microwave ablation related effects were local pain(NRS 4 to 6) and fever(mild to moderate).Overall,the above adverse effects were fully relieved after sympotomatic treatment,without severe complications and surgery-related deaths.Conclusion:In the therapy of primary hepatocarcinoma,imaging-guided cold-cycle microwave ablation in combination with TACE showed merits of obvious curative effect,little trauma,high safety and easy operation,which made it an effective combined minimally-invasive treatment method in targeting primary hepatocarcinoma.

Ultrasound guided percutaneous microwave coagulation therapy for liver carcinoma:32 cases clinical analysis

Clinical Assessment of Sonographically Guided Microwave Coagulation Therapy in Patients with Liver Carcinoma

Efficacy and Potential MicroRNA Mechanism for Computed Tomography-Guided Percutaneous Radiofrequency Ablation of Primary Lung Cancer and Lung Metastasis from Liver Cancer

Clinical Assessment of Percutaneous Microwave Ablation for Liver Tumors Abutting Special Locations under B Ultrasound Guidance

Clinical Analysis of Ultrasound-guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma

Clinical Analysis of Therapeutic Effects of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatic Metastases

Analysis of Percutaneous Microwave Coagulation Therapy with Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma in 27 Cases

Safety and Effectiveness Analysis of Percutaneous Microwave Thermal Ablation Therapy Combined Brachytherapy for Lung Malignant Lesion

Short-term effects of percutaneous microwave coagulation therapy combined with chemotherapy in the treatment of advanced non-small cell lung cancer

Clinical study on microwave ablation combined with transcatheter arterial chemoembolization in treating 46 cases of primary hepatocellular carcinoma

Microwave ablation in combination with TACE for the treatment of primary hepatic carcinoma

Clinical research on the cold-cycle microwave ablation in combination with TACE in the treatment of primary hepatocarcinoma

Application of Contrast Enhanced Ultrasonography in Microwave Ablation for Liver Cancer

Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined With Percutaneous Microwave Coagulation Therapy for Advanced Hepatocellular Carcinoma

Ultrasound-guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma Originating in the Caudate Lobe: A Pilot Clinical Study

Clinical evaluation of CT-guided percutaneous microwave ablation of non-small cell lung cancer

Analysis of Percutaneous microwave coagulation therapy for aged peripheral lung cancer patient

Analysis of the Clinical Efficacy of Liver Resection Combined with Adjuvant Microwave Coagulation for Patients with Hepatocellular Carcinoma

Microwave Surgery in the Treatment of Hepatocellular Carcinoma

Ultrasound-guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma: Clinical Outcomes and Prognostic Factors

Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients